Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 27, 1122-1131, June 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frindel, E.
Right arrow Articles by Tubiana, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frindel, E.
Right arrow Articles by Tubiana, M.

Kinetics of Cell Proliferation of an Experimental Tumor

Emilia Frindel, Edmond P. Malaise, Edward Alpen1 and Maurice Tubiana

Institut Gustave-Roussy, Villejuif, Seine, France

The cellular proliferation kinetics of an experimental fibrosarcoma in C3H mice have been studied in vitro and in vivo at various stages in tumor growth.

The duration of the cell cycle measured in vitro is the same as that measured in vivo and does not change when the increase in cell number, at first exponential, slows progressively. The slowing down of the growth rate and the plateau in vitro are explained mainly by a reduction in the proportion of cells engaged in the cell cycle and by increasing cell death.

In vivo, the growth rate is at first rapid and then slows progressively. The duration of the cell cycle is similar in all phases of tumor growth. A diminution both of the number of labeled cells after multiple injections of tritiated thymidine and of the growth fraction is seen as the growth rate slows. It is probable that in this case also increasing cell death contributes to the slowing of tumor growth. Autoradiographs in large tumors after multiple injections show considerable heterogeneity in labeling from one region of the tumor to another.

1 Present address: U. S. Naval Research Laboratory, San Francisco, California.

Received 9/19/66. Accepted 2/16/67.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1967 by the American Association for Cancer Research.